Most recently Senior Vice President, Corporate Strategy and Business Development Eli Lilly (Retired)
Mr. Santini has served on our board of directors since March 2012. Mr. Santini currently serves as the chairman of the board of directors of AMAG Pharmaceuticals, Inc.; on the board of directors of Intercept Pharmaceuticals, Inc., Vitae Pharmaceuticals, Inc. and Allena Pharmaceuticals, Inc., Artax Biopharma, Collegium Pharmaceuticals, Intarcia Therapeutics and is retired from a distinguished career with Eli Lilly and Company that spanned nearly three decades. Mr. Santini previously served on the board of directors for Sorin SpA from 2012 to 2015, when it was acquired by LivaNova plc. Mr. Santini capped his career at Lilly as a member of the company’s executive committee and as the senior vice president of corporate strategy and business development. Mr. Santini, fluent in four languages, holds an undergraduate degree in mechanical engineering from the University of Bologna and a master’s in business administration from the University of Rochester.